Fibromyalgia
Conditions
Keywords
Fibromyalgia, Affect, Pain, Fatigue, Sleep, Stress, Quality of Life, Stress, Psychological, Psychophysiology, Randomized Controlled Trials
Brief summary
The investigators are studying whether a brief three-session mind-body workshop helps people with fibromyalgia. The investigators hypothesize that this workshop will significantly improve pain and other symptoms, compared to usual care.
Detailed description
The affective self-awareness approach presumes that many chronic pain states, such as fibromyalgia (FM), can be effectively treated by encouraging self-awareness of emotional tension. While anecdotally effective in selected patients, this approach has thus far not been tested in a randomized controlled trial. Our purpose is to determine whether an affective self-awareness approach significantly improves pain, tenderness, and other FM symptoms in a random sample of FM patients; and to determine what psychosocial factors predict a favorable response. Comparisons: changes in ratings of pain, tenderness, and other symptoms between two arms of the study: * three weekly 2-hour small-group meetings supplemented with daily writing and meditative exercises to enhance affective self-awareness * usual care
Interventions
BEHAVIORALAffective Self-Awareness workshop
Affective Self Awareness intervention: 90 minute face-to-face consultation with the treating physician, then three 2-hour weekly small-group workshops involving education regarding Mind-Body connections, written emotional expression, meditation, and self-affirmation practices.
Sponsors
St. John Providence Hospital
Blue Care Network of Michigan
Mike Hsu
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* fibromyalgia, as defined by American College of Rheumatology 1990 criteria. * at least 18 years of age. * have access to transportation to and from Providence Hospital, Southfield, MI.
Exclusion criteria
* co-morbid medical conditions capable of causing a worsening of physical functional status independent of FM, including morbid obesity, autoimmune diseases, cardiopulmonary disorders (e.g. angina, congestive heart failure, COPD, chronic asthma), uncontrolled endocrine or allergic disorders (e.g. thyroid dysfunction, Type I diabetes), pregnancy, and malignancy within the preceding 2 years. * any present psychiatric disorder involving a history of psychosis (e.g. schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder etc.), post-traumatic stress disorder, current suicide risk or history of suicide attempt, or substance abuse within 2 years. Note: Subjects with mood or anxiety disorders otherwise will not be excluded. * changes in medication regimen within one month prior to enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in average pain according to the Brief Pain Inventory | 6 months |
Secondary
| Measure | Time frame |
|---|---|
| Medical Outcomes Study sleep subscale | 6 months |
| Perceived Stress Scale | 6 months |
| SF-36 Physical Functional Status | 6 months |
| Change in Multi-dimensional Fatigue Inventory | 6 months |
| Tender point count | 6 months |
| Dolorimeter tender point score | 6 months |
| Ascending and Multiple Random Staircase thumbnail sensitivity thresholds | 6 months |
| Profile of Mood States | 6 months |
Countries
United States
Outcome results
None listed